Product Information
DICYCLOMINE 10 MG/5 ML SOLN is a generic product labeled by Endo USA Inc., priced at $0.1736 per ML under NDC 00603116158. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 24, 2005. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the dicyclomine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/5mL
Manufacturer
Endo USA Inc.NDC
00603116158
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICYCLOMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040169FDA Approved
3/24/2005
TE Code
AA
On Market Since
6/23/2005
Pharmacological Classes
Price Statistics
The NADAC for DICYCLOMINE 10 MG/5 ML SOLN has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1736 per ML |
|---|---|
| All-time high | $0.2514 (Nov 16, 2016) |
| All-time low | $0.1409 (Jul 17, 2024) |
| 52-week high | $0.1868 |
| 52-week low | $0.1736 |
| Median price | $0.2104 |
| Average price | $0.2079 |
| Largest weekly change | +31.1% (Sep 20, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dicyclomine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dicyclomine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICYCLOMINE 10 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for DICYCLOMINE 10 MG/5 ML SOLN, manufactured by Endo USA Inc., is $0.1736 per ML (NDC 00603116158), effective Sep 30, 2026.
How has the price of DICYCLOMINE 10 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for DICYCLOMINE 10 MG/5 ML SOLN has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DICYCLOMINE 10 MG/5 ML SOLN?
Since Nov 28, 2013, the NADAC for DICYCLOMINE 10 MG/5 ML SOLN has ranged from a low of $0.1409 (Jul 17, 2024) to a high of $0.2514 (Nov 16, 2016), with a median of $0.2104 per ML.
Are there cheaper alternatives to DICYCLOMINE 10 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of DICYCLOMINE 10 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICYCLOMINE 10 MG/5 ML SOLN?
DICYCLOMINE 10 MG/5 ML SOLN (NDC 00603116158) is labeled by Endo USA Inc., and CMS classifies it as a generic product.